Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

Purple Biotech retains all worldwide rights ... “We are honored to be selected by the ASCO committee with our late breaking abstract poster presentation and are looking forward to presenting ...

REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT ... today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer ...